Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.

Marteau, TM, Munafò, MR, Aveyard, P et al. (11 more authors) (2010) Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence. BMC Public Health, 10. 680. p. 680. ISSN 1471-2458

Abstract

Metadata

Authors/Creators:
  • Marteau, TM
  • Munafò, MR
  • Aveyard, P
  • Hill, C
  • Whitwell, S
  • Willis, TA https://orcid.org/0000-0002-0252-9923
  • Crockett, RA
  • Hollands, GJ
  • Johnstone, EC
  • Wright, AJ
  • Prevost, AT
  • Armstrong, D
  • Sutton, S
  • Kinmonth, AL
Copyright, Publisher and Additional Information: © 2010 Marteau et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
Keywords: Adult; Communication; England; Ganglionic Stimulants; Genotype; Humans; Molecular Targeted Therapy; Nicotine; Patient Compliance; Receptors, Opioid, mu; Research Design; Smoking; Smoking Cessation; State Medicine; Surveys and Questionnaires
Dates:
  • Published: 9 November 2010
  • Accepted: 9 November 2010
  • Published (online): 9 November 2010
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Health Sciences (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 24 May 2018 12:26
Last Modified: 24 May 2018 12:26
Status: Published
Publisher: Biomed Central
Identification Number: https://doi.org/10.1186/1471-2458-10-680
Related URLs:

Share / Export

Statistics